Guaifenesin And Pseudoephedrine Hcl Tablet, Extended Release
FDA Label NDC 62207-827

17 label sections · Submitted to the FDA by Granules India Ltd · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Granules India Ltd for the product Guaifenesin And Pseudoephedrine Hcl (NDC 62207-827). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients (in each extended-release tablet), purposes, uses, warnings, ask a doctor before use if you have, when using this product, stop use and ask a doctor if, otc - pregnancy or breast feeding, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients (In Each Extended-Release Tablet)

(For 600 mg/60 mg)

Guaifenesin USP, 600 mg

Pseudoephedrine HCL USP, 60 mg


(For 1200 mg/120 mg)


Guaifenesin USP, 1200 mg
Pseudoephedrine HCL USP, 120 mg

Purposes

Expectorant

Nasal Decongestant

Uses

• helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

• temporarily relieves nasal congestion due to:
• common cold
• hay fever
• upper respiratory allergies

• temporarily restores freer breathing through the nose

• promotes nasal and/or sinus drainage

• temporarily relieves sinus congestion and pressure

Warnings

 Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Directions

• do not crush, chew, or break extended-release tablet

• take with a full glass of water

• this product can be administered without regard for timing of meals

• adults and children 12 years and older:

For 600 mg/60 mg: 2 extended-release tablets every 12 hours; not more than 4 extended-release tablets in 24 hours

For 1200 mg/120 mg: 1 extended-release tablet every 12 hours; not more than 2 extended-release tablets in 24 hours

• children under 12 years of age: do not use

Other Information

• Tamper evident: do not use if carton is open or if printed seal on blister is broken or missing.

• store between 20-25°C (68-77°F)

Inactive Ingredients

carbomer homopolymer Type B, cellulose microcrystalline, hypromellose, lake of FD&C yellow 6, magnesium stearate, sodium starch glycolate Type A

Questions Or Comments?

Contact 1-877-770-3183 Mon-Fri 8:00 AM EST to 5:00 PM PST.

You may also report side effects to this phone number.

Keep the carton.
It contains important information. See end panel for expiration date.


Manufactured By:
Granules India Limited
Hyderabad – 500 081, INDIA

MADE IN INDIA

Distributed By:
Granules USA, Inc.
Parsippany, NJ 07054

Principal Display Panel 600 Mg And 60 Mg - Blister Foil Label

Ggf-pseudo-600mg-60mg-foil-label (Ggf Pseudo 600mg 60mg Foil Label)

Ggf-pseudo-600mg-60mg-foil-label (Ggf Pseudo 600mg 60mg Foil Label)

* Please review the disclaimer below.